News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ilya Tsimafeyeu Presented Phase 2 SBRT Trial in Oligoprogressive Urothelial Cancer on Avelumab at ASCO 2025
Ilya Tsimafeyeu/bucare.org
Jun 7, 2025, 05:44

Ilya Tsimafeyeu Presented Phase 2 SBRT Trial in Oligoprogressive Urothelial Cancer on Avelumab at ASCO 2025

Ilya Tsimafeyeu, Director at the Bureau of Cancer Re­search, shared a post on Facebook:

“Our randomized phase 2 study of stereotactic body radiation therapy in patients with oligoprogressive metastatic urothelial cancer receiving maintenance avelumab was announced at the Trials in Progress session at ASCO25.”

Urothelial Cancer

More posts featuring Ilya Tsimafeyeu on OncoDaily.

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Urothelial Cancer

ASCO ASCO 2025 ASCO25 Avelumab Bureau of Cancer Re­search cancer Ilya Tsimafeyeu Oligoprogressive Urothelial Cancer OncoDaily Oncology radiation therapy
Special Coverage
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care
Science
Jun 26, 2025, 17:29
Myeloma Paper of the Day, June 26th, Suggested by Robert Orlowski
Oncolibrary
Jun 26, 2025, 14:50
What Is a Chemotherapy Port? Uses, Benefits and Complications
OncoDaily Pulse
Jun 26, 2025, 14:45
Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night
Blog
Jun 26, 2025, 14:20
Sendurai Mani: Gratitude and Great Science at our Lab Retreat
Oncolibrary
Jun 26, 2025, 14:14
MASCC 2025 Highlights: MuReva OM Dramatically Reduces Severe Oral Mucositis in HNC
Oncolibrary
Jun 26, 2025, 14:12
MASCC 2025 Highlights: Key Toxicity Findings in ADC-Treated Cancer Patients